This poster is published under an
open license. Please read the
disclaimer for further details.
Keywords:
Breast, Percutaneous, Biopsy, Cancer
Authors:
P. Merino Rasillo, E. Ortega García, P. Alonso Bartolomé, S. M. Sanchez Gomez, S. Sánchez Bernal, A. Vega Bolivar; Santander/ES
DOI:
10.1594/ecr2015/C-0644
References
1.
Pfarl G,
Helbich TH,
Riedl CC,
et al.
Stereotactic11-gauge vacuum-assisted breast biopsy: a validation study.
AJR 2002; 179:1503–1507
2.
Sigal-Zafrani B,
Muller K,
El Khoury C,
et al.
Vacuum-assisted large-core needle biopsy(VLNB) improves the management of patients with breast microcalcifications: analysis of 1009 cases.
Eur J Surg Oncol 2008; 34:377–381
3.
Jackman RJ,
Burbank F,
Parker SH,
et al.
Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with a 14-gauge directional vacuum biopsy.
Radiology 1997; 204:485–488
4.
Jackman RJ,
Burbank F,
Parker SH,
et al.
Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
Radiology 2001; 218:497–502
5.
Georgian-Smith D,
Lawton TJ.
Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective.
Radiol Clin North Am 2010; 48:999–1012
6.
Lawton TJ,
Georgian-Smith D.
Excision of highrisk breast lesions on needle biopsy: is there a standard of core? AJR 2009; 192:W268
7.
Berg WA.
Image-guided breast biopsy and management of high-risk lesions.
Radiol Clin North Am 2004; 42:935–946
8.
Philpotts LE,
Shaheen NA,
Jain KS,
Carter D,
Lee CH.
Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance.
Radiology 2000; 216:831–837